Navigation Links
VirtualScopics Announces 1-for-10 Reverse Stock Split
Date:8/21/2013

result, the Company might receive a delisting notice from NASDAQ. The Company plans to appeal any such notice, which would stay the delisting pending the outcome of the appeal. The Company also plans to continue working with NASDAQ during that time to regain compliance.

Continental Stock Transfer & Trust will act as the Company's Exchange Agent in connection with the reverse stock split. Stockholders will receive the notices, forms and instructions regarding the exchange of their pre-split shares for post-split shares from the Exchange Agent or their broker. No fractional shares will be issued in connection with the reverse stock split. Stockholders who would otherwise be entitled to receive a fractional share will receive cash in lieu of the fractional share.

Additional information regarding the reverse stock split can be found in the Company's definitive proxy statement filed with the Securities and Exchange Commission on July 2, 2013.

About VirtualScopics, Inc.VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development.  VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images.  In combination with VirtualScopics' industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, allowing sponsors to make better decisions faster.  For more information about VirtualScopics, visit www.virtualscopics.com.

Forward-Looking StatementsThe statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be
'/>"/>

SOURCE VirtualScopics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. VirtualScopics Reports Dr. Mostafa Analoui Elected Chairman of the Board
2. VirtualScopics Reports Second Quarter 2013 Results
3. VirtualScopics Schedules Second Quarter 2013 Earnings Announcement
4. VirtualScopics Reports First Quarter 2013 Results
5. VirtualScopics Receives Additional Time to Regain Compliance with Nasdaq
6. VirtualScopics Reports Fourth-Quarter and Full-Year 2012 Results
7. VirtualScopics Schedules Fourth Quarter and Full Year 2012 Earnings Announcement
8. VirtualScopics Reports 3rd Quarter 2012 Results
9. VirtualScopics Receives Issuance of Influential Patent in Canada
10. VirtualScopics to Present at the Upcoming Rodman & Renshaw Annual Global Investment Conference
11. VirtualScopics Announces Receipt of Notice from Nasdaq
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Apr. 17, 2015 Research and Markets ... "ADME-Toxicology Testing - Global Strategic Business Report" ... the worldwide markets for ADME-Toxicology Testing in US$ Million ... and ADME Testing. The report provides separate ... , Japan , Europe ...
(Date:4/17/2015)... Research and Markets ( http://www.researchandmarkets.com/research/vrd3bd/mammography ) ... - Global Strategic Business Report" report to their ... for Mammography Equipment in US$ Thousands by the following ... The report provides separate comprehensive analytics for the US, ... , Europe , Asia-Pacific ...
(Date:4/17/2015)... -- Today, the Pharmaceutical Research and Manufacturers of ... companies as "We Work For Health Champions" for ... service. Established in 2009, the We ... the biopharmaceutical industry to honor employees who have ... also shown an outstanding commitment to their communities ...
Breaking Medicine Technology:ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2Mammography Equipment (Analog & Digital) Market 2015-2020 - Global Strategic Business Report: Breast Imaging Screening Programs Push Sales 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 3
... Texas , Feb. 3 Lexicon Pharmaceuticals, Inc. ... and developing breakthrough treatments for human disease, announced today that ... officer, will present at the 2010 BIO CEO & Investor Conference ... at 9:30 a.m., Eastern Time . The conference is ...
... , PITTSBURGH , Feb. 3 An ... work together to fight cancer.  Now, drug response markers such ... help to determine individual cancer treatment plans when using various ... Therapeutics, Inc., a life sciences company in Pittsburgh, Pennsylvania ...
Cached Medicine Technology:Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference 2Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference 3Patients, Physicians Rely on ChemoFx(R) to Support Their Cancer Treatment Decisions 2Patients, Physicians Rely on ChemoFx(R) to Support Their Cancer Treatment Decisions 3
(Date:4/17/2015)... 17, 2015 As a board-certified orthopedic ... new offering of platelet-rich plasma (PRP) and ... is known for its world-class care of injury-caused ... surgical experience lacking in many other physicians offering regenerative ... are utilized for pain management and rehabilitation. Dr. Meier ...
(Date:4/17/2015)... 17, 2015 Baptist Health and The ... a partnership agreement designed to transform oncology care in ... have agreed to create a joint cancer program to ... translational research. Baptist MD Anderson Cancer Center is anticipated ... single destination for highly coordinated, multidisciplinary cancer care for ...
(Date:4/17/2015)... 2015 Connie Casad, M.D., a well-known ... advocate with 30 years of practice experience in Dallas, ... level of service for her patients with the availability ... recommended wellness books with a brief synopsis on each ... her interest in providing this service, Dr. Casad said, ...
(Date:4/17/2015)... 2015 Oxytocin is a ... and thought to help mothers bond to their newborn, ... substantiate this, new studies performed, at NYU Langone Medical ... reported by Medical News Today on April 16, 2015, ... maternal social behavior. The study reveals that, when oxytocin ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Ticket Down is a ... their 2015 Summer Tour. , The life of last-minute show announcements ... the popular group perform during the early part of 2015, but ... Will Wait,” “Little Lion Man,” “The Cave,” and “Believe,” will perform ... on June 2 at MCU Park at Coney Island in Brooklyn, ...
Breaking Medicine News(10 mins):Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 2Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 3Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:Connie Casad, M.D. Provides Patients Recommended List of Wellness Books on Website 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 3Health News:Mumford and Sons Tickets in Clarkston/Detroit, Raleigh, Columbia/Baltimore, Chicago, Mansfield/Boston, Brooklyn, Calgary and Edmonton Now On Sale 2
... Teenagers and young adults with cancer are being ... trials with the 13-24 age group in mind and ... to those trials that do exist, according to new ... University College Hospital, London, told Teenage Cancer Trust,s Fifth ...
... June 2008 A 115-year-old woman who remained mentally ... with little or no evidence of Alzheimer,s disease, according ... of Aging ( http://neurobiologyofaging.org/ ). , The findings question ... dementia will inevitably develop, if people live long enough. ...
... specialist nurse clinic rather than a consultant-led clinic for ... and good symptom management, according to a paper in ... , And because the clinical nurse specialist was ... consultations without referring issues to the consultant, patients also ...
... Gentag, Inc. and MacroArray,Technologies, LLC have entered into ... Gentag,s cell phone communication,technology and MacroArray,s urine diagnostic ... males are at risk of developing prostate cancer, ... order to simplify and expand,the use of low ...
... ATS Medical, Inc.,(Nasdaq: ATSI ), manufacturer ... services, today noted that several key opinion ... Medical products and related,procedures during the scientific ... Invasive Cardiothoracic Surgery (ISMICS) annual,meeting in Boston., ...
... (NASDAQ: QLTI; TSX:,QLT) announced today that QLT USA, ... purchase agreement with Allergan Sales, LLC, a,wholly-owned subsidiary ... fully divest QLT,s,worldwide rights to Aczone(R), a prescription ... for the treatment of acne vulgaris. Under the,terms ...
Cached Medicine News:Health News:Organizers of cancer clinical trials are neglecting teenagers and young adults 2Health News:Organizers of cancer clinical trials are neglecting teenagers and young adults 3Health News:World's oldest woman had normal brain 2Health News:Specialist nurses can play a key role in supporting patients having radiotherapy 2Health News:Specialist nurses can play a key role in supporting patients having radiotherapy 3Health News:Gentag, Inc. and MacroArray Technologies Join Forces 2Health News:ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations 2Health News:ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations 3Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 2Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 3Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 4Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 5
The workhorse electric system....
... The BD Safety Knife with BD Xstar ... shield that protects the blade in prodedure ... is based on a grind-less process for ... yields outstanding sharpness and consistency. The ...
... Safety Knife with BD Xstar Blade includes ... protects the blade in prodedure and handling. ... on a grind-less process for manufacturing surgical ... sharpness and consistency. The arch style, ...
... The BD Safety Knife with BD ... retractable shield that protects the blade in ... technology is based on a grind-less process ... process yields outstanding sharpness and consistency. ...
Medicine Products: